A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)
Status: | Terminated |
---|---|
Conditions: | Neurology, Orthopedic |
Therapuetic Areas: | Neurology, Orthopedics / Podiatry |
Healthy: | No |
Age Range: | 21 - 85 |
Updated: | 10/19/2018 |
Start Date: | September 2011 |
End Date: | September 2016 |
A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System(DSS)
The purpose of the Post-Market Surveillance study is to evaluate safety.
Paradigm Spine Dynamic Stabilization System (DSS) study is a prospective, multi-center,
literature controlled study.
literature controlled study.
Inclusion Criteria:
- Patient is skeletally mature (21-85 years old).
- Patient has degenerative spondylolisthesis (Grade 1-3) with objective evidence of
neurologic impairment, kyphosis, and/or failed previous fusion (pseudarthrosis) at
index level.
- Capable and willing to comply with the requirements unique to the study, adhere to the
post-operative treatment and management program, and return for required follow-up
examinations.
- Surgeon has determined that DSS™ System is an appropriate treatment for the patient
without regard to the study.
Exclusion Criteria:
- The need for interbody cages, allograft, or any other assistance during surgery.
Device is only to be used with autograft per FDA approved indications.
- Any medical, mental or surgical condition precluding the potential benefit of spinal
surgery or surgery in general.
- Acute or chronic systemic, spinal or localized infections.
- Active, severe systemic and metabolic diseases.
- Obesity defined as Body Mass Index > 35.
- Subject is pregnant or interested in becoming pregnant in the next 36 months.
- Dependency on pharmaceutical drugs, drug abuse, or alcoholism.
- Lack of patient cooperation.
- Foreign body sensitivity to the implant material.
- Degenerative scoliosis greater than 25 degrees.
- Grade 4 degenerative spondylolisthesis (>75% slip).
- Significant osteopenia A screening questionnaire for osteopenia, SCORE (Simple
Calculated Osteoporosis Risk Estimation), will be used to screen patients who require
a DEXA bone mineral density measurement. If DEXA is required*, exclusion will be
defined as a DEXA bone density measured T score of ≤ -1.0 (The World Health
Organization definition of osteopenia).
- Soft tissue deficit not allowing wound closure.
- Congenital abnormalities, tumors or other conditions that would prevent secure
component fixation that has the potential to decrease the useful life of the device.
- Inadequate pedicles or vertebral body geometry of the thoracic, lumbar and sacral
vertebrae.
- Bony lumbar spinal stenosis not related to the primary degenerative spondylolisthesis
indication.
- Pars defect.
- Clinically compromised vertebral bodies at affected level due to current or past
trauma.
- Prisoner or ward of the state.
- Currently in litigation regarding a spinal condition.
- Known allergy to titanium, titanium alloys, CoCrMo, polyethylene or MR contrast
agents.
- Is currently involved in a study of another investigational product for similar
purpose.
We found this trial at
1
site
2315 Stockton Blvd.
Sacramento, California 95817
Sacramento, California 95817
(916) 734-2011

Principal Investigator: Rolando F. Roberto, MD
Phone: 916-734-3660
University of California, Davis Medical Center UC Davis Medical Center serves a 65,000-square-mile area that...
Click here to add this to my saved trials
